Skip to main content

Table 1 Univariate analysis of correlation between phosphorylation of transgelin-2 at S145 residue and clinicopathologocial factors

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variables

Total (n)

p-S145-transgelin-2 level

p value

 

Positive n(%)

Negative n(%)

 

Sex

 Male

69

39(64)

30(57)

0.544

 Female

45

22(36)

23(43)

 

Age at Surgery (years)

  < 65

66

38(62)

28(53)

0.406

  ≥ 65

48

23(38)

25(47)

 

Tumour Differentiation

 Well/Moderate

79

38(62)

41(77)

0.125

 Poor

35

23(38)

12(23)

 

Tumor Stage

 I-II

53

22(36)

31(58)

0.027

 III-IV

61

39(64)

22(42)

 

Tumor location

 Head

87

48(79)

39(74)

0.676

 Others

27

13(21)

14(26)

 

Tumor Size

  < 2 cm

36

13(21)

23(43)

0.020

  ≥ 2 cm

78

48(79)

30(57)

 

Metastasis status

 Patients with metastasis

2

2(3)

0(0)

0.539

 Patients without metastasis

112

59(97)

53(100)

 

Lymph Node Involvement

 Positve

58

37(61)

21(40)

0.040

 Negative

56

24(39)

32(60)

 

Vascular invastion

 Positve

72

40(66)

32(60)

0.705

 Negative

42

21(34)

21(40)

Â